alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### Frank Ciarleglio et al. *v.*Bernard Shapiro, Welfare Commissioner, et al.

King, C. J., Alcorn, House, Thim: and Ryan, Js.

Argued December 10

decided December 10, 1968

*Frank A. Francis,*with whom was *Seymour L. Kroopnick,*for the appellants (plaintiffs).

*Francis J. MacGregor,*assistant attorney general, for the appellee (named defendant).

*Albert J. Callahan,*pro se as guardian ad litem for the appellee (defendant Anthony Ciarleglio).

Per Curiam.

The plaintiffs seek to set aside a decree of adoption, rendered by the Probate Court for the district of Hartford, on the ground that the welfare commissioner failed to comply with the requirements of that portion of what is now General Statutes § 45-63 which requires that he shall, in his report to the Probate Court, “indicate the physical and mental status of the child.” The subordinate facts support the conclusion of the trial court that there was no basis for setting aside the decree.

There is no error.
**Exhibit 32.2**

 

**CERTIFICATIONPURSUANT TO**

 

**18 U.S.C.SECTIONS 1350,**

 

**ASADOPTED PURSUANT TO**

 

**SECTION 906OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with theQuarterly Report on Form 10-Q of Ebix, Inc. (the “Company”) for theperiod ended March 31, 2008, as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Robert Kerris, Chief FinancialOfficer of the Company, certify, pursuant to 18 U.S.C. 1350, as adoptedpursuant to 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fullycomplies with the requirements of section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

 

2. The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 
| By:                     | /s/ Robert F. Kerris |   |
|-------------------------|----------------------|--------|
|                    |                 |   |
| Name:                   | Robert F. Kerris     |   |
|                    |                 |   |
| Chief Financial Officer |                 |
|                    |                 |   |
| May 6, 2008        |                 |

 

----
# C_2015026EN.01004801.xml

| 26.1.2015 | EN | Official Journal of the European Union | C 26/48 |
| --- | --- | --- | --- |

26.1.2015

EN

Official Journal of the European Union

C 26/48

---

Action brought on 23 October 2014 — ZZ v Council

(Case F-118/14)

(2015/C 026/64)

Language of the case: French

Parties

Parties

Applicant: ZZ (represented by: C. Garcia-Hirschfeld)

Applicant:

Defendant: Council of the European Union

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Annulment of Council decisions on the classification of officials in grades AD 9 to AD 14 occupying posts identified as holding special responsibilities in the type of post ‘Head of unit or equivalent’ or ‘Adviser or equivalent’ before 31 December 2015 and not placing the applicant among the officials so classified.

Form of order sought

Form of order sought

The applicant claims that the Tribunal should:

| — | annul the decision Noo6/14 of the appointing authority of 3 January 2014 and the subsequent decision to assign 34 Council officials to the type of post ‘Head of unit or equivalent’; |
| --- | --- |

—

annul the decision Noo6/14 of the appointing authority of 3 January 2014 and the subsequent decision to assign 34 Council officials to the type of post ‘Head of unit or equivalent’;

o

| — | annul, if necessary, the decision of 23 July 2014 rejecting the complaint; |
| --- | --- |

—

annul, if necessary, the decision of 23 July 2014 rejecting the complaint;

| — | order the Council of the European Union to pay the costs. |
| --- | --- |

—

order the Council of the European Union to pay the costs.

---
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.4220 Cardiopulmonary bypass heart-lung machine console. ( a ) *Identification.* A cardiopulmonary bypass heart-lung machine console is a device that consists of a control panel and the electrical power and control circuitry for a heart-lung machine. The console is designed to interface with the basic units used in a gas exchange system, including the pumps, oxygenator, and heat exchanger.
( b ) *Classification.* Class II (performance standards).
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.2300 Multipurpose culture medium. ( a ) *Identification.* A multipurpose culture medium is a device that consists primarily of liquid or solid biological materials intended for medical purposes for the cultivation and identification of several types of pathogenic microorganisms without the need of additional nutritional supplements. Test results aid in the diagnosis of disease and also provide epidemiological information on diseases caused by these microorganisms.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9.
[47 FR 50823, Nov. 9, 1982, as amended at 54 FR 25046, June 12, 1989; 66 FR 38790, July 25, 2001]
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
FINANCIAL STATEMENTS INCLUDED IN FORM 10-QSB AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                         391,399
<SECURITIES>                                         0
<RECEIVABLES>                                5,399,759
<ALLOWANCES>                                 3,528,956
<INVENTORY>                                    891,794
<CURRENT-ASSETS>                             3,801,912
<PP&E>                                       2,111,159
<DEPRECIATION>                                 353,684
<TOTAL-ASSETS>                              18,310,807
<CURRENT-LIABILITIES>                        4,398,835
<BONDS>                                      8,308,822
<PREFERRED-MANDATORY>                        1,667,480
<PREFERRED>                                          0
<COMMON>                                    16,897,938
<OTHER-SE>                                (13,129,168)
<TOTAL-LIABILITY-AND-EQUITY>                18,310,807
<SALES>                                      6,576,649
<TOTAL-REVENUES>                             6,585,996
<CGS>                                        4,903,232
<TOTAL-COSTS>                                7,591,161
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             472,888
<INCOME-PRETAX>                            (1,478,053)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,478,053)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,478,053)
<EPS-PRIMARY>                                   (1.16)
<EPS-DILUTED>                                   (1.16)
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               Mar-31-1999
<CASH>                                          38,071
<SECURITIES>                                         0
<RECEIVABLES>                                2,518,405
<ALLOWANCES>                                    56,549
<INVENTORY>                                  1,784,563
<CURRENT-ASSETS>                             5,841,213
<PP&E>                                       9,626,786
<DEPRECIATION>                               7,117,041
<TOTAL-ASSETS>                               8,524,349
<CURRENT-LIABILITIES>                        3,948,103
<BONDS>                                      5,844,941
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           414
<OTHER-SE>                                  (8,273,751)
<TOTAL-LIABILITY-AND-EQUITY>                 8,524,349
<SALES>                                      3,531,308
<TOTAL-REVENUES>                             3,531,308
<CGS>                                        3,326,117
<TOTAL-COSTS>                                3,326,117
<OTHER-EXPENSES>                               563,583
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             132,850
<INCOME-PRETAX>                               (483,792)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (483,792)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (483,792)
<EPS-BASIC>                                    (0.01)
<EPS-DILUTED>                                    (0.01)


</TABLE>
[Federal Register Volume 75, Number 43 (Friday, March 5, 2010)]
[Notices]
[Page 10332]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4802]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of: Corridor Communications Corp., International 
Cosmetics Marketing Co., PNV, Inc., Questron Technology, Inc. (n/k/a 
Quti Corp.), Tapistron International, Inc., Telscape International, 
Inc. (n/k/a Scapetel Debtor, Inc.), and Universal Beverages Holdings 
Corp.; Order of Suspension of Trading

March 3, 2010.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Corridor Communications Corp. because it has not filed any periodic 
reports since the period ended September 30, 2004.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
International Cosmetics Marketing Co. because it has not filed any 
periodic reports since the period ended March 31, 2003.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
PNV, Inc. because it has not filed any periodic reports since the 
period ended September 30, 2000.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Questron Technology, Inc. (n/k/a Quti Corp.) because it has not filed 
any periodic reports since the period ended September 30, 2001.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Tapistron International, Inc. because it has not filed any periodic 
reports since the period ended April 30, 2001.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Telscape International, Inc. (n/k/a Scapetel Debtor, Inc.) because it 
has not filed any periodic reports since the period ended December 31, 
2000.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Universal Beverages Holdings Corp. because it has not filed any 
periodic reports since the period ended September 30, 2003.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed companies. Therefore, it is ordered, 
pursuant to Section 12(k) of the Securities Exchange Act of 1934, that 
trading in the securities of the above-listed companies is suspended 
for the period from 9:30 a.m. EST on March 3, 2010, through 11:59 p.m. 
EDT on March 16, 2010.

    By the Commission.
Elizabeth M. Murphy,
Secretary.
[FR Doc. 2010-4802 Filed 3-3-10; 4:15 pm]
BILLING CODE 8011-01-P
# C_2014351EN.01003002.xml

| 6.10.2014 | EN | Official Journal of the European Union | C 351/30 |
| --- | --- | --- | --- |

6.10.2014

EN

Official Journal of the European Union

C 351/30

---

Order of the Civil Service Tribunal (1st Chamber) of 26 June 2014 — DL v Commission

(Case F-13/14) (1)

1

((Removal from the register - Withdrawal by the applicant - Article 89(7) of the Rules of Procedure - Agreement of the parties on costs))

2014/C 351/40

Language of the case: French

Parties

Parties

Applicant: DL (Orp-Jauche, Belgium) (represented by: S. Orlandi, lawyer)

Applicant:

Defendant: European Commission (represented by: J. Currall and V. Joris, Agents)

Defendant:

Re:

Re:

Application for annulment of the decision rejecting the request for extension, for the year 2012/2013, of the reimbursement of the costs of speech therapy for the applicant’s son as part of the treatment of his serious illness.

Operative part of the order

Operative part of the order

| 1. | Case F-13/14 is removed from the register of the Tribunal. |
| --- | --- |

1.

Case F-13/14 is removed from the register of the Tribunal.

| 2. | DL and the European Commission are to pay the costs in accordance with their agreement. |
| --- | --- |

2.

DL and the European Commission are to pay the costs in accordance with their agreement.

---

(1)  OJ C 102, 7.4.2014, p. 46.

1

---
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7823 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7823

To amend the Federal Food, Drug, and Cosmetic Act to require a warning 
label advising that the effects of mifepristone can be counteracted, to 
 amend the Public Health Service Act to establish a hotline to provide 
information to women seeking to counteract the effects of mifepristone, 
                        and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 26, 2024

   Mrs. Miller of Illinois (for herself, Mr. Babin, Ms. Hageman, Mr. 
  Rosendale, Mrs. Harshbarger, Mr. Banks, and Mr. Webster of Florida) 
 introduced the following bill; which was referred to the Committee on 
                          Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
To amend the Federal Food, Drug, and Cosmetic Act to require a warning 
label advising that the effects of mifepristone can be counteracted, to 
 amend the Public Health Service Act to establish a hotline to provide 
information to women seeking to counteract the effects of mifepristone, 
                        and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Second Chance for Moms Act''.

SEC. 2. MIFEPRISTONE WARNING LABEL AND HOTLINE.

    (a) Warning Label.--
            (1) In general.--Section 502 of the Federal Food, Drug, and 
        Cosmetic Act (21 U.S.C. 352) is amended by adding at the end 
        the following:
    ``(hh) If it is the drug mifepristone, and its labeling does not 
bear the following statement printed in conspicuous text: `WARNING: 
Medical evidence suggests that the abortifacient effects of 
mifepristone can be counteracted by natural progesterone, which can 
increase the chance of fetal survival. The American Society for 
Reproductive Medicine has determined that natural progesterone is safe 
in the first trimester of pregnancy. For more information, call [___].' 
(with the blank filled in to refer to the appropriate number for the 
hotline under section 1009 of the Public Health Service Act).''.
            (2) Effective date.--Section 502(hh) of the Federal Food, 
        Drug, and Cosmetic Act (as added by paragraph (1)) applies 
        beginning on the date that is 6 months after the date of 
        enactment of this Act.
    (b) Hotline.--Title X of the Public Health Service Act (42 U.S.C. 
300 et seq.) is amended by adding at the end the following:

``SEC. 1009. HOTLINE FOR REVERSAL OF EFFECTS OF MIFEPRISTONE.

    ``The Secretary shall establish or maintain, directly or by grant 
or contract, a toll-free hotline to provide support for 24 hours a day, 
7 days a week, for women seeking to reverse the effects of the drug 
mifepristone.''.
                                 <all>
```
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE 
COMPANY'S CONSOLIDATED FINANCIAL STATEMENTS OF INCOME AND CONSOLIDATED
BALANCE SHEETS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-START>                             APR-01-1997
<PERIOD-END>                               DEC-27-1997
<CASH>                                      54,857,000
<SECURITIES>                                10,492,000
<RECEIVABLES>                               91,607,000
<ALLOWANCES>                               (4,217,000)
<INVENTORY>                                 84,792,000
<CURRENT-ASSETS>                           243,589,000
<PP&E>                                      10,854,000
<DEPRECIATION>                             (6,277,000)
<TOTAL-ASSETS>                             248,952,000
<CURRENT-LIABILITIES>                      182,799,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    26,850,000
<OTHER-SE>                                  39,303,000
<TOTAL-LIABILITY-AND-EQUITY>               248,952,000
<SALES>                                    332,408,000
<TOTAL-REVENUES>                           332,408,000
<CGS>                                      297,087,000
<TOTAL-COSTS>                              297,087,000
<OTHER-EXPENSES>                            23,998,000
<LOSS-PROVISION>                               278,000
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                             12,594,000
<INCOME-TAX>                                 4,723,000
<INCOME-CONTINUING>                          7,871,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 7,871,000
<EPS-PRIMARY>                                     1.39
<EPS-DILUTED>                                     1.38
        

</TABLE>
Exhibit 32.1










CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002






In connection with the Annual Report of Preferred Voice, Inc. (the "Company") on Form 10-K for the period ending March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Mary G. Merritt, Principal Executive Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:




(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and




(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.




June 24, 2011By:
/s/ Mary G. MerrittMary G. MerrittPrincipal Executive Officer

Principal Financial Officer
38919.

#### WARREN v. WARREN, Administratrix.

Decided July 14, 1961.

*Edward Parrish, Elsie Griner,*for plaintiff in error.

*Virgil D. Griffis,*contra.

Felton, Chief Judge.

The principal ground of the plaintiff in error’s caveat is the allegation that the sale of the land of the intestate’s estate was unnecessary. This is based partially upon the alleged agreement on the part of the widow, Mrs. Warren, to pay the largest single debt of the estate out of the income from the farm, and partially upon the caveator’s offer to pay the remaining debts of the estate himself. The evidence does not show the existence of a binding contract between the widow and the heirs at law to such effect. The testimony was only that the heirs agreed to such an arrangement. She was allowed to take possession of the farm and the dwelling house thereon “for the rest of her life” by the unanimous consent of the twelve heirs at law.

The caveator failed to rebut satisfactorily the testimony as to the infeasibility of division of the land and the necessity of a sale *185for the purpose of distribution, and this is one of the purposes for which land may be sold by an administrator under *Code Ann.*§ 113-1706. The order by the ordinary’s court is in effect not only leave to sell, but is an adjudication by a court of competent jurisdiction that it is necessary for the land to be administered for *one or the other or both of the purposes*indicated in *Code Ann.*§§ 113-901 and 113-1706 (i. e., for payment of debts and distribution among the heirs) and that it is for the benefit of the heirs and creditors. *Wilcox v. Thomas,*191 Ga. 319 (1, 3) (12 SE2d 343); *Kelley v. Cromer,*201 Ga. 375, 376 (2) (39 SE2d 880). Therefore if either reason for selling the land is found by the court to exist, the sale may be authorized.

The plaintiff in error raises a point in his brief which was not included in his caveat, i. e., that the administratrix did not first acquire possession of the land from the heirs at law in her capacity as administratrix before attempting to sell the land. Even if this contention could be urged at this time, it would not have had sufficient merit to justify denying an order granting her leave to sell the land. Neither her possession of the land nor that of anyone else was adverse to the estate. If the widow held the land adversely to the estate her institution of proceedings to sell as administratrix would estop her from attacking the validity of the sale.

Since the evidence demanded the verdict, the court did not err in directing a verdict in favor of the adminintratrix.

*Judgment affirmed.*

*Bell and Hall, JJ., concur.*
# Exhibit 32



CERTIFICATION



The undersigned certify pursuant to 18 U.S.C. § 1350, that:



(1)    The accompanying Quarterly Report on Form 10-Q for the period ended June 30, 2006, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)    The information contained in the accompanying Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date:   August 4, 2006

| | /s/   Marti Morfitt                               
| | --------------------------------------------------
| | Marti Morfitt, President & Chief Executive Officer

Date:   August 4, 2006

| | /s/   Samuel E. Reinkensmeyer                                                         
| | --------------------------------------------------------------------------------------
| | Samuel E. ReinkensmeyerVice President of Finance, ChiefFinancial Officer and Treasurer

---